A share price of Applied Therapeutics Inc [APLT] is currently trading at $0.57, down -1.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The APLT shares have gain 4.42% over the last week, with a monthly amount drifted -13.74%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Applied Therapeutics Inc [NASDAQ: APLT] stock has seen the most recent analyst activity on December 23, 2024, when William Blair downgraded its rating to a Mkt Perform. Previously, UBS downgraded its rating to Neutral on December 02, 2024, and dropped its price target to $2. On November 29, 2024, downgrade downgraded it’s rating to Sector Perform and revised its price target to $4 on the stock. William Blair started tracking the stock assigning a Outperform rating. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $12 as its price target on March 26, 2024. Leerink Partners started tracking with a Outperform rating for this stock on February 22, 2024, and assigned it a price target of $12. In a note dated January 04, 2022, Barclays downgraded an Equal Weight rating on this stock and revised its target price from $44 to $7.
Applied Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.54 and $10.62. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. Applied Therapeutics Inc [NASDAQ: APLT] shares were valued at $0.57 at the most recent close of the market. An investor can expect a potential return of 689.47% based on the average APLT price forecast.
Analyzing the APLT fundamentals
Gross Profit Margin for this corporation currently stands at 3.79% with Operating Profit Margin at 437.36%, Pretax Profit Margin comes in at 887.73%, and Net Profit Margin reading is 887.73%. To continue investigating profitability, this company’s Return on Assets is posted at -1.76, Equity is -5.83 and Total Capital is -12.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5502 points at the first support level, and at 0.5351 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5901, and for the 2nd resistance point, it is at 0.6149.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Applied Therapeutics Inc [NASDAQ:APLT] is 1.06. As well, the Quick Ratio is 1.06, while the Cash Ratio is 1.0.
Transactions by insiders
Recent insider trading involved Funtleyder Leslie D.,, that happened on Feb 06 ’25 when 22950.0 shares were sold. Chief Medical Officer, Perfetti Riccardo completed a deal on Feb 06 ’25 to sell 86078.0 shares. Meanwhile, Chinoporos Constantine sold 28117.0 shares on Feb 06 ’25.
